These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 590534

  • 1. The use of gonadotropins for the induction of ovulation in women with polycystic ovarian disease.
    Raj SG, Berger MJ, Grimes EM, Taymor ML.
    Fertil Steril; 1977 Dec; 28(12):1280-4. PubMed ID: 590534
    [Abstract] [Full Text] [Related]

  • 2. WITHDRAWN: Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E, Collins J, Vandekerckhove P.
    Cochrane Database Syst Rev; 1996 Apr 22; (1):CD000087. PubMed ID: 17636586
    [Abstract] [Full Text] [Related]

  • 3. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E, Collins J, Vandekerckhove P.
    Cochrane Database Syst Rev; 2000 Apr 22; 1996(2):CD000087. PubMed ID: 10796690
    [Abstract] [Full Text] [Related]

  • 4. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.
    Homburg R, Eshel A, Kilborn J, Adams J, Jacobs HS.
    Hum Reprod; 1990 Jan 22; 5(1):32-5. PubMed ID: 2108981
    [Abstract] [Full Text] [Related]

  • 5. [Contribution of human menopausal gonadotropins purified as to their FSH content in anovulatory sterility presenting a difficult treatment problem].
    Emperaire JC, Ruffié A, Audebert AJ.
    J Gynecol Obstet Biol Reprod (Paris); 1987 Jan 22; 16(5):621-6. PubMed ID: 3117873
    [Abstract] [Full Text] [Related]

  • 6. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S, Adams J, Mason H, Polson D.
    Clin Obstet Gynaecol; 1985 Sep 22; 12(3):605-32. PubMed ID: 3933879
    [Abstract] [Full Text] [Related]

  • 7. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S, Paradisi R, Fabbri R, Porcu E, Orsini LF, Flamigni C.
    Int J Fertil; 1987 Sep 22; 32(1):66-70. PubMed ID: 2880819
    [Abstract] [Full Text] [Related]

  • 8. Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins.
    Charbonnel B, Krempf M, Blanchard P, Dano F, Delage C.
    Fertil Steril; 1987 Jun 22; 47(6):920-4. PubMed ID: 2954858
    [Abstract] [Full Text] [Related]

  • 9. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.
    van Weissenbruch MM, Schoemaker HC, Drexhage HA, Schoemaker J.
    Hum Reprod; 1993 Jun 22; 8(6):813-21. PubMed ID: 8345068
    [Abstract] [Full Text] [Related]

  • 10. Use of human urinary follicle-stimulating hormone in infertile women with polycystic ovaries.
    Flamigni C, Venturoli S, Paradisi R, Fabbri R, Porcu E, Magrini O.
    J Reprod Med; 1985 Mar 22; 30(3):184-8. PubMed ID: 3923189
    [Abstract] [Full Text] [Related]

  • 11. The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries.
    Prelevic GM, Ginsburg J, Maletic D, Hardiman P, Okolo S, Balint-Peric L, Thomas M, Orskov H.
    Hum Reprod; 1995 Jan 22; 10(1):28-32. PubMed ID: 7745065
    [Abstract] [Full Text] [Related]

  • 12. Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy.
    Neyro JL, Barrenetxea G, Montoya F, Rodriguez-Escudero FJ.
    Hum Reprod; 1991 Feb 22; 6(2):218-21. PubMed ID: 1905311
    [Abstract] [Full Text] [Related]

  • 13. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome.
    Larsen T, Larsen JF, Schiøler V, Bostofte E, Felding C.
    Fertil Steril; 1990 Mar 22; 53(3):426-31. PubMed ID: 2106449
    [Abstract] [Full Text] [Related]

  • 14. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH, Sy L, Cannon W.
    Am J Obstet Gynecol; 1981 Jul 15; 140(6):629-35. PubMed ID: 6167169
    [Abstract] [Full Text] [Related]

  • 15. Measurement of serum levels of exogenously administered FSH and LH during ovulation induction therapy.
    Mallya S, Abdulla UA, Davis JC.
    Gynecol Endocrinol; 1993 Sep 15; 7(3):167-71. PubMed ID: 8291453
    [Abstract] [Full Text] [Related]

  • 16. Changes in serum immunoreactive inhibin during ovulation induction in women with amenorrhea.
    Takagi T, Mizunuma H, Andoh K, Obara M, Yamaguchi M, Hasegawa Y, Ibuki Y.
    Endocr J; 1994 Dec 15; 41(6):703-8. PubMed ID: 7704095
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women.
    Nakamura Y, Yoshimura Y, Tanabe K, Iizuka R.
    Fertil Steril; 1986 Jul 15; 46(1):46-54. PubMed ID: 3087790
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
    Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S.
    Hum Reprod; 1995 Oct 15; 10(10):2545-9. PubMed ID: 8567767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.